☆ 4.7 Article

Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Correction Microbiology

Erratum for Zhang et al., Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital (vol 10, e01690-22, 2022)

Na Zhang et al.

MICROBIOLOGY SPECTRUM (2022)

添加到收藏夹

Article Infectious Diseases

Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections

Haiyang Meng et al.

Summary: This study aimed to identify risk factors for mortality and outcomes in hematological malignancy patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae. The study found that HM patients with CRKP BSI had a high mortality rate. ICU admission, higher Pitt bacteremia score, and absolute neutrophil count < 500 at discharge were independently associated with higher mortality. Early initiation of a new drug such as ceftazidime-avibactam may improve outcomes.

INFECTION AND DRUG RESISTANCE (2022)

添加到收藏夹

Article Infectious Diseases

Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study

Guanhao Zheng et al.

Summary: The study evaluated the efficacy and safety of ceftazidime/avibactam and polymyxin B in treating carbapenem-resistant Klebsiella pneumoniae infection. The results showed that ceftazidime/avibactam was more effective than polymyxin B in treating CRKP-infected patients. Additionally, the combination of ceftazidime/avibactam with tigecycline or amikacin showed a lower mortality rate. A treatment period lasting over 7 days was recommended, and caution should be taken regarding the hepatotoxicity of ceftazidime/avibactam and the nephrotoxicity of polymyxin B.

INFECTIOUS DISEASES AND THERAPY (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Carbapenem-resistant Enterobacteriaceae bloodstream infections: A case-control study from a pediatric referral hospital in Argentina

Silvina Ruvinsky et al.

Summary: This study found that CRE-BSI mainly affects hospitalized children, especially after liver transplantation, with previous urinary catheter use and broad-spectrum antibiotic treatment, potentially leading to high PICU requirements and mortality.

FRONTIERS IN PUBLIC HEALTH (2022)

添加到收藏夹

Correction Microbiology

Erratum for Zhang et al., Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital

Na Zhang et al.

MICROBIOLOGY SPECTRUM (2022)

添加到收藏夹

Article Immunology

Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals

Jeffrey R. Strich et al.

Summary: The study showed an increasing use of ceftazidime-avibactam for carbapenem-resistant gram-negative infections, while the use of colistin declined during the same period. Patients with chronic kidney disease were more likely to receive targeted ceftazidime-avibactam therapy, while those on dialysis were less likely to receive it compared to colistin.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children

M. F. Ara-Montojo et al.

Summary: The study evaluated predictors of 30-day mortality in carbapenem-resistant Enterobacteriaceae bloodstream infection in children, finding a high mortality rate. Risk factors for increased mortality included organ transplant recipients, intensive care admission, and inadequate empirical therapy.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

添加到收藏夹

Article Infectious Diseases

Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals

Sameer S. Kadri et al.

Summary: Approximately one in five patients with bloodstream infections in US hospitals received discordant empirical antibiotic therapy, which was closely associated with increased odds of mortality. Early identification of bloodstream pathogens and resistance will probably improve population-level outcomes.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study

Mario Tumbarello et al.

Summary: The study found that there was no significant difference in 30-day mortality rates between patients treated with ceftazidime-avibactam alone and those treated with combination regimens for managing infections caused by carbapenem-resistant Enterobacteriaceae. Factors such as septic shock and neutropenia at infection onset were positively associated with mortality, while prolonged infusion of CAZ-AVI was negatively associated with mortality. Further research is needed to explore the potential survival benefits of prolonging CAZ-AVI infusions in certain types of infections.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study

Jie Fang et al.

Summary: This study compared the efficacy of polymyxin B versus ceftazidime-avibactam in Chinese patients with CRKP infections, revealing that CAZ/AVI was more effective with lower mortality rates and better treatment outcomes. Multivariate and Cox regression analysis identified Charlson comorbidity index and prior antibiotic use as risk factors affecting efficacy and mortality rates.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Molecular mechanisms in septic shock (Review)

Gabriel Gorecki et al.

Summary: Sepsis is a clinical syndrome characterized by infection and systemic inflammatory response, resulting from a complex interaction between host and infectious agents. It is associated with activation of multiple inflammatory pathways and increased risk of mortality. The incidence of sepsis has been on the rise in recent years, with various clinical situations predisposing individuals to its occurrence and involving a range of pathogens.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

添加到收藏夹

Article Health Care Sciences & Services

Risk Factors of 30-Day All-Cause Mortality in Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection

Keh-Sen Liu et al.

Summary: This study identified risk factors of 30-day all-cause mortality in patients with CRKP BSI, including microbiologic eradication > 7 days, lower platelet count, and a higher Pitt bacteremia score. These findings provide new insights into the clinical landscape of CRKP BSI.

JOURNAL OF PERSONALIZED MEDICINE (2021)

添加到收藏夹

Review Health Care Sciences & Services

Predictors of mortality in patients with carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis and a systematic review

Yiyi Qian et al.

Summary: Septic shock, congestive heart failure, COPD, CKD, diabetes mellitus, mechanical ventilation, and inappropriate empirical antimicrobial treatment are risk factors associated with mortality in patients with carbapenem-resistant Klebsiella pneumoniae infection. The APACHE II score can be used to assess disease severity and predict patient outcomes.

ANNALS OF PALLIATIVE MEDICINE (2021)

添加到收藏夹

Article Immunology

In vitro evaluation of antibiotic synergy for carbapenem-resistan Klebsiella pneumoniae clinical isolates

Anku Goel et al.

Summary: The study tested antibiotic combinations for synergy against clinical isolates of carbapenem-resistant Klebsiella pneumoniae (CRKP), with imipenem and tigecycline followed by meropenem and colistin being found to be the most effective combinations. No synergy was detected for levofloxacin and polymyxin B combination.

INDIAN JOURNAL OF MEDICAL RESEARCH (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China

Yuanyuan Li et al.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)

添加到收藏夹

Article Immunology

Clinical Observation and Prognostic Analysis of Patients With Klebsiella pneumoniae Bloodstream Infection

Shuguang Zhang et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

添加到收藏夹

Review Infectious Diseases

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children

Kathleen Chiotos et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)

添加到收藏夹

Article Critical Care Medicine

Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae

Marco Falcone et al.

CRITICAL CARE (2020)

添加到收藏夹

Article Immunology

Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K-pneumoniae

Mario Tumbarello et al.

CLINICAL INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Infectious Diseases

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection

Qiqiang Liang et al.

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Immunology

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections

Sarah C. J. Jorgensen et al.

OPEN FORUM INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Immunology

Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro

Lan Yu et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

添加到收藏夹

Article Infectious Diseases

Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients

Ye Zhang et al.

BMC INFECTIOUS DISEASES (2018)

添加到收藏夹

Article Infectious Diseases

Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo--Lactamase-1

Fang Dong et al.

MICROBIAL DRUG RESISTANCE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Stereotypic Immune System Development in Newborn Children

Axel Olin et al.

CELL (2018)

添加到收藏夹

Article Immunology

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children

Kathleen Chiotos et al.

OPEN FORUM INFECTIOUS DISEASES (2018)

添加到收藏夹

Article Immunology

Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia

Pranita D. Tamma et al.

CLINICAL INFECTIOUS DISEASES (2017)

添加到收藏夹

Review Infectious Diseases

Use of tigecycline in pediatric clinical practice

Maria Vincenza Mastrolia et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)

添加到收藏夹

Article Immunology

Monocyte Subsets Are Differentially Lost from the Circulation during Acute Inflammation Induced by Human Experimental Endotoxemia

Tamar Tak et al.

JOURNAL OF INNATE IMMUNITY (2017)

添加到收藏夹

Article Immunology

Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India

Laura E. B. Nabarro et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)

添加到收藏夹

Review Microbiology

Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae

Liangfei Xu et al.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)

添加到收藏夹

Article Infectious Diseases

Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias

Alessandra Micozzi et al.

BMC INFECTIOUS DISEASES (2017)

添加到收藏夹

Review Infectious Diseases

Carbapenem-Resistant Enterobacteriaceae Infections in Children

Kathleen Chiotos et al.

CURRENT INFECTIOUS DISEASE REPORTS (2016)

添加到收藏夹

Article Hematology

Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey

Enrico Maria Trecarichi et al.

AMERICAN JOURNAL OF HEMATOLOGY (2016)

添加到收藏夹

Article Microbiology

Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections

A. Gomez-Simmonds et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

添加到收藏夹

Article Immunology

Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia

Alejandro Diaz et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)

添加到收藏夹

Review Immunology

Monocyte-mediated defense against bacteria, fungi, and parasites

Gregoire Lauvau et al.

SEMINARS IN IMMUNOLOGY (2015)

添加到收藏夹

Review Immunology

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections

Haley J. Morrill et al.

OPEN FORUM INFECTIOUS DISEASES (2015)

添加到收藏夹

Article Immunology

Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012

Latania K. Logan et al.

EMERGING INFECTIOUS DISEASES (2015)

添加到收藏夹

Review Immunology

Neonatal Immune Adaptation of the Gut and Its Role during Infections

Emilie Tourneur et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)

添加到收藏夹

Article Infectious Diseases

Predictive scoring model of mortality in Gram-negative bloodstream infection

M. N. Al-Hasan et al.

CLINICAL MICROBIOLOGY AND INFECTION (2013)

添加到收藏夹

Review Infectious Diseases

Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections

Pierluigi Viale et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)

添加到收藏夹

Article Immunology

Infections Caused by Carbapenem-resistant Gram-negative Pathogens in Hospitalized Children

Helena C. Maltezou et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)

添加到收藏夹

Article Immunology

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

Mario Tumbarello et al.

CLINICAL INFECTIOUS DISEASES (2012)

添加到收藏夹

Article Immunology

Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials

Paritosh Prasad et al.

CLINICAL INFECTIOUS DISEASES (2012)

添加到收藏夹

Review Microbiology

Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions

L. S. Tzouvelekis et al.

CLINICAL MICROBIOLOGY REVIEWS (2012)

添加到收藏夹

Review Infectious Diseases

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

G. L. Daikos et al.

CLINICAL MICROBIOLOGY AND INFECTION (2011)

添加到收藏夹

Article Hematology

Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists

James L. Wynn et al.

BLOOD (2008)

添加到收藏夹

Review Medicine, General & Internal

Neonatal survival 1 - 4 million neonatal deaths: When? where? why?

JE Lawn et al.

LANCET (2005)

添加到收藏夹

Article Pediatrics

Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis

I Nupponen et al.

PEDIATRICS (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.